🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT06672770
Starting soon Not applicable

Effect of Functional Inspiratory Muscle Training in Patients with Multiple Sclerosis

NCT06672770 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2024-11-01
Last updated
2024-11-04

Condition(s) studied

Core MusclesFunctional Inspiratory Muscle TrainingMultiple SclerosisRespiratory Muscles

Investigational drug(s) / intervention(s)

Functional Inspiratory Muscle TrainingBasic Inspiratory Muscle Training

Functional Inspiratory Muscle Training: The functional inspiratory muscle training group will perform basic inspiratory muscle training in the first four weeks of the study and the following exercises with the Powerbreath device in muscle training in the following four weeks: 1. Diaphragmatic breathing exercises 2. Warm-up exercises 3. Trunk strength and lumbopelvic stability exercises 4. Dynamic trunk exercises 5. Postural control exercises 6. Cool-down exercises

Basic Inspiratory Muscle Training: The basic inspiratory muscle training group will do muscle training with the POWERbreathe device for eight weeks.

Study summary

This study aims to investigate the effects of functional inspiratory muscle training, basic inspiratory muscle training and physical activity in addition to respiratory exercises on respiratory muscle strength, respiratory function, cognition, walking, balance, functional exercise capacity, physical activity, quality of life and core muscles in volunteer Multiple Sclerosis (MS) patients. This study is planned as a prospective, randomized and experimental study.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Diagnosed with Relapsing Remitting Type Multiple Sclerosis (RRMS), * EDSS (Expanded Disability Status Scale in MS: EDSS) score ranging from 1-5, * Able to communicate (speak, understand, read and understand Turkish), * Individuals who have not had an attack in the last three months, * Individuals who have not received respiratory-based rehabilitation in the last six months will be included in the study. Exclusion Criteria: * Those with neurological diseases other than MS, * Those who have functional exercise restrictions, * Those with chronic cardiac or pulmonary diseases such as chronic obstructive pulmonary disease (COPD), asthma, interstitial lung disease and heart failure that may affect respiratory muscle strength and respiratory functions, * Individuals who have had pneumonia due to viral or bacterial infection in the last six months or COVID-19 positive individuals proven by PCR-RT, * Those with orthopedic problems, persistent neck and back pain and/or radiculopathy that prevent them from participating in the study, * Those with diagnosed psychiatric disorders, * Those who use tobacco and tobacco products, * Participants with cooperation problems that may prevent evaluations and treatment will not be included in the study.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Selcuk University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation Konya Selcuklu

More Selcuk University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06672770 on ClinicalTrials.gov ↗ ← All trials in Turkey